[HTML][HTML] Evidence-based pharmacological treatment options for ADHD in children and adolescents
K Mechler, T Banaschewski, S Hohmann… - Pharmacology & …, 2022 - Elsevier
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
characterized by inattention, hyperactivity, and impulsivity, causing functional impairment. Its …
[HTML][HTML] The association between type 2 diabetes and attention-deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling study
We conducted a systematic review and a meta-analysis to quantitatively summarize
evidence on the association between attention-deficit/hyperactivity disorder (ADHD) and …
evidence on the association between attention-deficit/hyperactivity disorder (ADHD) and …
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
JJS Kooij, D Bijlenga, L Salerno, R Jaeschke… - European …, 2019 - cambridge.org
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …
[图书][B] Adult ADHD: Diagnostic assessment and treatment
JJS Kooij - 2012 - books.google.com
Adult ADHD: Diagnostic Assessment and Treatment, Third Edition covers not only diagnostic
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …
[HTML][HTML] An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
BS Da Silva, EH Grevet, LCF Silva, JKN Ramos… - Discover Mental …, 2023 - Springer
Abstract Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent psychiatric condition
characterized by developmentally inappropriate symptoms of inattention and/or …
characterized by developmentally inappropriate symptoms of inattention and/or …
Current pharmacological treatments for ADHD
MJ Groom, S Cortese - New Discoveries in the Behavioral Neuroscience of …, 2022 - Springer
Abstract Attention-Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental
condition associated with impaired function and increased risk of poor outcomes in children …
condition associated with impaired function and increased risk of poor outcomes in children …
A phase II double-blind, placebo-controlled, efficacy and safety study of SPN-812 (extended-release viloxazine) in children with ADHD
JK Johnson, T Liranso, K Saylor… - Journal of attention …, 2020 - journals.sagepub.com
Objective: The objective of this study is to evaluate efficacy and safety of SPN-812 (extended-
release viloxazine) for ADHD in children aged 6 to 12 years. Method: In an 8-week study …
release viloxazine) for ADHD in children aged 6 to 12 years. Method: In an 8-week study …
Identification of novel high-affinity substrates of OCT1 using machine learning-guided virtual screening and experimental validation
O Jensen, J Brockmöller… - Journal of medicinal …, 2021 - ACS Publications
OCT1 is the most highly expressed cation transporter in the liver and affects
pharmacokinetics and pharmacodynamics. Newly marketed drugs have previously been …
pharmacokinetics and pharmacodynamics. Newly marketed drugs have previously been …
[HTML][HTML] Methylphenidate alleviates cognitive dysfunction caused by early manganese exposure: Role of catecholaminergic receptors
SA Beaudin, S Howard, N Santiago, BJ Strupp… - Progress in Neuro …, 2024 - Elsevier
Environmental manganese (Mn) exposure is associated with impaired attention and
psychomotor functioning, as well as impulsivity/hyperactivity in children and adolescents …
psychomotor functioning, as well as impulsivity/hyperactivity in children and adolescents …
[HTML][HTML] Vitamin B6 deficiency hyperactivates the noradrenergic system, leading to social deficits and cognitive impairment
K Toriumi, M Miyashita, K Suzuki, N Yamasaki… - Translational …, 2021 - nature.com
We have reported that a subpopulation of patients with schizophrenia have lower levels of
vitamin B6 (VB6) in peripheral blood than do healthy controls. In a previous study, we found …
vitamin B6 (VB6) in peripheral blood than do healthy controls. In a previous study, we found …